Cargando…

Heparin-binding epidermal growth factor-like growth factor is a potent regulator of invasion activity in oral squamous cell carcinoma

Heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF) has been shown to stimulate the growth of various cell types in an autocrine or paracrine manner. Although HB-EGF is widely expressed in tumors when compared with normal tissue, its contribution to cancer progression remains o...

Descripción completa

Detalles Bibliográficos
Autores principales:	OHNISHI, YUICHI, INOUE, HIROSHI, FURUKAWA, MASAYUKI, KAKUDO, KENJI, NOZAKI, MASAMI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2011
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583476/ https://www.ncbi.nlm.nih.gov/pubmed/22209887 http://dx.doi.org/10.3892/or.2011.1616

Ejemplares similares

Effects of epidermal growth factor on the invasive activity and cytoskeleton of oral squamous cell carcinoma cell lines
por: OHNISHI, YUICHI, et al.
Publicado: (2014)

NANOG expression correlates with differentiation, metastasis and resistance to preoperative adjuvant therapy in oral squamous cell carcinoma
por: WATANABE, MASAHIRO, et al.
Publicado: (2014)

A heparin-modified thermoresponsive surface with heparin-binding epidermal growth factor-like growth factor for maintaining hepatic functions in vitro and harvesting hepatocyte sheets
por: Arisaka, Yoshinori, et al.
Publicado: (2016)

Heparin-binding epidermal growth factor-like growth factor suppresses experimental liver fibrosis in mice
por: Huang, Guangcun, et al.
Publicado: (2012)

Fibrogenic Effects of Heparin-Binding Epidermal Growth Factor-like Growth Factor: Myeloid or Epithelial Origin?
por: Martin, James G., et al.
Publicado: (2022)

Cyclin D1 expression is correlated with cell differentiation and cell proliferation in oral squamous cell carcinomas
por: OHNISHI, YUICHI, et al.
Publicado: (2014)

Heparin-binding epidermal growth factor-like growth factor and hepatocyte growth factor inhibit cholestatic liver injury in mice through different mechanisms
por: Sakamoto, Kouichi, et al.
Publicado: (2016)

Clinical significance of heparin-binding epidermal growth factor-like growth factor in peritoneal fluid of ovarian cancer
por: Yagi, H, et al.
Publicado: (2005)

Heparin-Binding Epidermal Growth Factor-like Growth Factor/Diphtheria Toxin Receptor in Normal and Neoplastic Hematopoiesis
por: Vinante, Fabrizio, et al.
Publicado: (2013)

Autocrine expression of the epidermal growth factor receptor ligand heparin-binding EGF-like growth factor in cervical cancer
por: Schrevel, Marlies, et al.
Publicado: (2017)

Locally administered heparin-binding epidermal growth factor-like growth factor reduces radiation-induced oral mucositis in mice
por: Chen, Jing, et al.
Publicado: (2020)

Serum Amphiregulin and Heparin-Binding Epidermal Growth Factor as Biomarkers in Patients with Idiopathic Inflammatory Myopathy
por: Hanata, Norio, et al.
Publicado: (2021)

Heparin-Binding Epidermal Growth Factor-like growth factor eliminates constraints on activated Kras to promote rapid onset of pancreatic neoplasia
por: Ray, Kevin C., et al.
Publicado: (2013)

Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma
por: Van Hiep, Nguyen, et al.
Publicado: (2022)

Novel Antagonists of Heparin Binding Growth Factors
por: Cecchi, Fabiola, et al.
Publicado: (2012)

Corrigendum: Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma
por: Van Hiep, Nguyen, et al.
Publicado: (2022)

Prenatal administration of heparin-binding epidermal growth factor-like growth factor in an experimental model of necrotizing enterocolitis decreased both incidence and severity of the disease
por: Sacks, Marla Ashley, et al.
Publicado: (2022)

Preservation of heparin-binding EGF-like growth factor activity on heparin-modified poly(N-isopropylacrylamide)-grafted surfaces
por: Kobayashi, Jun, et al.
Publicado: (2021)

Detection of epidermal growth factor receptor mutations in lung adenocarcinoma cytological specimens by immunocytochemistry
por: Yoshida, Masami, et al.
Publicado: (2017)

Association between uterine toxicity induced by chlorpyrifos and downregulation of heparin-binding epidermal growth factor and L-selectin genes
por: Gheibi, Parisa, et al.
Publicado: (2023)

The Epidermal Growth Factor-like Domain of CD93 Is a Potent Angiogenic Factor
por: Kao, Yuan-Chung, et al.
Publicado: (2012)

Heparin-binding EGF-like growth factor enhances the activity of invasion and metastasis in thyroid cancer cells
por: OTA, ICHIRO, et al.
Publicado: (2013)

Growth control by epidermal growth factor and transforming growth factor-alpha in human lung squamous carcinoma cells.
por: Rabiasz, G. J., et al.
Publicado: (1992)

Multiple influences of a heparin-binding growth factor on neuronal development
Publicado: (1987)

Endothelial Cell Capture of Heparin-Binding Growth Factors under Flow
por: Zhao, Bing, et al.
Publicado: (2010)

Heparin-conjugated collagen as a potent growth factor-localizing and stabilizing scaffold for regenerative medicine
por: Ikegami, Yasuhiro, et al.
Publicado: (2020)

Melatonin Pretreated Blastocysts along with Calcitonin Administration Improved Implantation by Upregulation of Heparin Binding-Epidermal Growth Factor Expression in Murine Endometrium
por: Moghani-Ghoroghi, Fatemeh, et al.
Publicado: (2018)

Heparin‐binding Epidermal Growth Factor‐like Growth Factor: p91 Activation, Induction of Plasminogen Activator/Plasminogen Activator Inhibitor, and Tubular Morphogenesis in Human Microvascular Endothelial Cells
por: Ushiro, Shin, et al.
Publicado: (1996)

The immunoexpression of epidermal growth factor receptor in cutaneous squamous cell carcinoma
por: Nichita, Mirela Marcela, et al.
Publicado: (2021)

Computational modeling of novel quinazoline derivatives as potent epidermal growth factor receptor inhibitors
por: Ibrahim, Muhammad Tukur, et al.
Publicado: (2020)

Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints
Publicado: (1990)

Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor.
por: Mellon, J. K., et al.
Publicado: (1996)

Expression and localization of epidermal growth factor, transforming growth factor-α and epidermal growth factor receptor in the canine testis
por: TAMADA, Hiromichi, et al.
Publicado: (2015)

Endometrial Heparin-Binding Epidermal Growth Factor Gene Expression and Hormone Level Changes in Implantation Window of Obese Women with Polycystic Ovarian Syndrome
por: Sutaji, Zulazmi, et al.
Publicado: (2023)

Characterization of a Drosophila protein that binds both epidermal growth factor and insulin-related growth factors
Publicado: (1987)

An insulin growth factor-I/II-neutralizing monoclonal antibody in combination with epidermal growth factor receptor inhibitors potently inhibits tumor cell growth
por: Ma, Guofang, et al.
Publicado: (2022)

Human Epidermal Growth Factor Receptor 2-Subtype Invasive Ductal Carcinoma Recurring as Basal-Human Epidermal Growth Factor Receptor 2-Subtype Squamous Cell Carcinoma
por: An, Jeongshin, et al.
Publicado: (2019)

A case of epidermal growth factor receptor tyrosine kinase inhibitor effectiveness in epidermal growth factor receptor mutation-positive squamous cell carcinoma
por: Matsumura, Sosuke, et al.
Publicado: (2023)

Laminin heparin-binding peptides bind to several growth factors and enhance diabetic wound healing
por: Ishihara, Jun, et al.
Publicado: (2018)

Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma.
por: Filipe, M. I., et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_mah3hmla539s3dmn3vqt1t5cbk